FI954738A0 - Tetrasykliini yhdisteet dopamiiniagonisteina - Google Patents
Tetrasykliini yhdisteet dopamiiniagonisteinaInfo
- Publication number
- FI954738A0 FI954738A0 FI954738A FI954738A FI954738A0 FI 954738 A0 FI954738 A0 FI 954738A0 FI 954738 A FI954738 A FI 954738A FI 954738 A FI954738 A FI 954738A FI 954738 A0 FI954738 A0 FI 954738A0
- Authority
- FI
- Finland
- Prior art keywords
- image
- dopamine agonists
- tetracycline compounds
- treatment
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4342493A | 1993-04-06 | 1993-04-06 | |
| US20998294A | 1994-03-17 | 1994-03-17 | |
| PCT/US1994/002894 WO1994022858A1 (en) | 1993-04-06 | 1994-03-18 | Tetracyclic compounds as dopamine agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI954738A0 true FI954738A0 (fi) | 1995-10-05 |
| FI954738A FI954738A (fi) | 1995-12-05 |
Family
ID=26720416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI954738A FI954738A (fi) | 1993-04-06 | 1995-10-05 | Tetrasykliini yhdisteet dopamiiniagonisteina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5597832A (fi) |
| EP (1) | EP0690863B1 (fi) |
| JP (1) | JP2710695B2 (fi) |
| KR (1) | KR100383342B1 (fi) |
| CN (1) | CN1046723C (fi) |
| AT (1) | ATE233765T1 (fi) |
| AU (1) | AU677842B2 (fi) |
| BR (1) | BR9405972A (fi) |
| DE (1) | DE69432217T2 (fi) |
| DK (1) | DK0690863T3 (fi) |
| ES (1) | ES2193158T3 (fi) |
| FI (1) | FI954738A (fi) |
| NO (1) | NO311762B1 (fi) |
| PT (1) | PT690863E (fi) |
| WO (1) | WO1994022858A1 (fi) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5659037A (en) * | 1994-08-18 | 1997-08-19 | Abbott Laboratories | Process for preparing chiral tetracyclic dopaminergic compounds |
| US5668141A (en) * | 1996-04-02 | 1997-09-16 | Abbott Laboratories | Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists |
| DE19644228A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
| DE69838789T2 (de) * | 1997-03-12 | 2008-10-30 | Suzanne Cambridge de la Monte | Verfahren zur behandlung oder prävention der alzheimerischen krankheit |
| US6193954B1 (en) | 1997-03-21 | 2001-02-27 | Abbott Laboratories | Formulations for pulmonary delivery of dopamine agonists |
| DE69811378T2 (de) | 1997-10-03 | 2004-02-12 | Cary Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) | Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion |
| US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
| GB9828861D0 (en) * | 1998-12-31 | 1999-02-17 | Danbiosyst Uk | Compositions |
| US5969159A (en) * | 1999-02-16 | 1999-10-19 | Great Lakes Chemical Corporation | Synthesis of cyclopentyl 2-thienyl ketone tiletamine and tiletamine acid addition salts such as tiletamine hydrochloride |
| US6147226A (en) * | 1999-02-16 | 2000-11-14 | Great Lakes Chemical Corporation | Synthesis of cyclopentyl 2-thienyl ketone, tiletamine and tiletamine acid addition salts, such as tiletamine hydrochloride |
| US6638929B2 (en) * | 1999-12-29 | 2003-10-28 | Wyeth | Tricyclic protein kinase inhibitors |
| KR20030024877A (ko) * | 2000-08-16 | 2003-03-26 | 파마시아 앤드 업존 캄파니 | 중독성 질환의 치료용 화합물 |
| DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
| US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
| DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DK1480647T3 (da) * | 2002-02-15 | 2009-01-26 | Darpharma Inc | Mono-ester eller asymmetrisk substituerede di-ester-prodrugs af dopamin-D1 receptoragonister |
| EP1626703A2 (en) * | 2003-05-22 | 2006-02-22 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
| WO2005055920A2 (en) * | 2003-12-09 | 2005-06-23 | Yeda Research And Development Co. Ltd. | Compositions and methods for treatment of psychiatric disorders |
| JP2007516292A (ja) * | 2003-12-23 | 2007-06-21 | ダーファーマ，インコーポレイテッド | ドーパミン受容体結合化合物の共投与 |
| CA2643300C (en) * | 2006-02-21 | 2011-11-08 | Purdue Research Foundation | Trans-fused chromenoisoquinolines, synthesis and methods for use |
| US9359303B2 (en) | 2009-04-21 | 2016-06-07 | Purdue Research Foundation | Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor |
| EP2822936B1 (en) | 2012-03-07 | 2021-09-08 | The McLean Hospital Corporation | Aminoquinoline derivatives and uses thereof |
| CN103387583B (zh) * | 2012-05-09 | 2018-04-13 | 中国科学院上海药物研究所 | 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用 |
| RU2537170C1 (ru) * | 2013-11-20 | 2014-12-27 | Войсковая Часть 41598 | Средство профилактики церебральной формы острой лучевой болезни |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2691024A (en) * | 1952-05-26 | 1954-10-05 | Schenley Ind Inc | Dihydropyrrolo-(3.2-c) quinoline derivatives |
| US3541100A (en) * | 1967-12-14 | 1970-11-17 | American Cyanamid Co | Benzheteroazolo(2,3-a)isoquinolium salts |
| GB1379387A (en) * | 1970-12-11 | 1975-01-02 | Agfa Gevaert | Photoconductive recording materials |
| US3943137A (en) * | 1973-07-09 | 1976-03-09 | University Of Kansas Endowment Association | Acronycine derivatives |
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| US4282227A (en) * | 1980-05-22 | 1981-08-04 | Smithkline Corporation | Renal vasodilating 3,4-dihydroxyphenyltetrahydrothienopyridines |
| US4340600A (en) * | 1980-05-22 | 1982-07-20 | Smithkline Corporation | Renal dilating methods and compositions using 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines |
| US5047536A (en) * | 1989-03-17 | 1991-09-10 | Purdue Research Foundation | Hexahydrobenzo(A)phenanthridine compounds |
| JP3476193B2 (ja) * | 1992-05-26 | 2003-12-10 | パーデュー・リサーチ・ファウンデーション | 置換ヘキサヒドロベンゾ〔α〕フェナンスリジン類 |
-
1994
- 1994-03-18 EP EP94912799A patent/EP0690863B1/en not_active Expired - Lifetime
- 1994-03-18 DK DK94912799T patent/DK0690863T3/da active
- 1994-03-18 BR BR9405972A patent/BR9405972A/pt not_active Application Discontinuation
- 1994-03-18 AU AU65203/94A patent/AU677842B2/en not_active Expired
- 1994-03-18 PT PT94912799T patent/PT690863E/pt unknown
- 1994-03-18 JP JP6522116A patent/JP2710695B2/ja not_active Expired - Lifetime
- 1994-03-18 ES ES94912799T patent/ES2193158T3/es not_active Expired - Lifetime
- 1994-03-18 AT AT94912799T patent/ATE233765T1/de active
- 1994-03-18 KR KR1019950704355A patent/KR100383342B1/ko not_active IP Right Cessation
- 1994-03-18 DE DE69432217T patent/DE69432217T2/de not_active Expired - Lifetime
- 1994-03-18 CN CN94192241A patent/CN1046723C/zh not_active Expired - Lifetime
- 1994-03-18 WO PCT/US1994/002894 patent/WO1994022858A1/en active IP Right Grant
- 1994-11-10 US US08/337,348 patent/US5597832A/en not_active Expired - Lifetime
-
1995
- 1995-10-05 NO NO19953957A patent/NO311762B1/no not_active IP Right Cessation
- 1995-10-05 FI FI954738A patent/FI954738A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2193158T3 (es) | 2003-11-01 |
| FI954738A (fi) | 1995-12-05 |
| DE69432217D1 (de) | 2003-04-10 |
| AU677842B2 (en) | 1997-05-08 |
| EP0690863A4 (en) | 1995-11-07 |
| US5597832A (en) | 1997-01-28 |
| NO953957L (no) | 1995-11-21 |
| ATE233765T1 (de) | 2003-03-15 |
| CN1046723C (zh) | 1999-11-24 |
| NO311762B1 (no) | 2002-01-21 |
| BR9405972A (pt) | 1995-12-12 |
| KR100383342B1 (ko) | 2003-08-25 |
| KR960701870A (ko) | 1996-03-28 |
| EP0690863B1 (en) | 2003-03-05 |
| PT690863E (pt) | 2003-07-31 |
| WO1994022858A1 (en) | 1994-10-13 |
| CN1124489A (zh) | 1996-06-12 |
| DK0690863T3 (da) | 2003-06-30 |
| JP2710695B2 (ja) | 1998-02-10 |
| DE69432217T2 (de) | 2004-04-08 |
| NO953957D0 (no) | 1995-10-05 |
| AU6520394A (en) | 1994-10-24 |
| EP0690863A1 (en) | 1996-01-10 |
| JPH08508487A (ja) | 1996-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI954738A0 (fi) | Tetrasykliini yhdisteet dopamiiniagonisteina | |
| GEP20022676B (en) | 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors | |
| KR100263496B1 (ko) | 탁솔 유도체 및 이의 제조방법 | |
| CA2269994A1 (en) | 7-hetero-bicyclo¬2.2.1|-heptanes | |
| HUP0203225A2 (hu) | Benzodiazepinszármazékok, előállításuk és alkalmazásuk | |
| ID22636A (id) | Zat-zat terapeutik | |
| CA2286723A1 (en) | Tricyclic compounds | |
| DK0667866T3 (da) | 1,4-benzothiazepiner anvendelige som neurologiske midler | |
| YU75601A (sh) | Postupak za pripremanje modulatora nesteroidnih glukokortikoidnih receptora | |
| DE69412016T2 (de) | Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| NO308658B1 (no) | Sammenføyde isoquinoliner som dopamin-reseptor-ligander | |
| DE602004007181D1 (de) | 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen | |
| DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| ES2150913T3 (es) | Enantiomeros de derivados de ciclopenteno. | |
| DK0707570T3 (da) | Isoquinolinderivater som terapeutiske midler | |
| CA2159481A1 (en) | Tetracyclic compounds as dopamine agonists | |
| AU6531296A (en) | Benzocycloalkene compounds with melatonine receptor binding affinity, their production and use | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| CA2213197A1 (en) | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands | |
| ES2004215A6 (es) | Procedimiento para preparar quinazolinas tetraciclicas | |
| MXPA03002532A (es) | Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| DE59103080D1 (de) | 9-Amino-2-phenylbicyclo[3.3.1]nonane und 9-Amino-2-phenylbicyclo[3.3.1]-non-2-ene und diese enthaltende therapeutische Mittel. | |
| CA2207443A1 (en) | Tricyclic compounds |